The Chinese GWAS used hyperuricaemic controls in follow-up testing to demonstrate that the newly discovered loci (BCAS3, RFX3 and KCNQ1) are likely to be involved in pathways leading to presentation with gout in people with hyperuricaemia [32]. This evidence concerns the gene BCAS3 and hyperuricemia.